2007 Annual Meeting

ASENT's 9th Annual Meeting

To view a session, click PPT Icon to view a PowerPoint slide presentation, Audio Icon to hear the audio, and Video Icon to view a video.

Thursday, March 8, 2007

Sixth Annual Advocacy Forum: Intellectual Property & Therapeutics Development

Title Speaker(s) Duration Presentation Audio Video
Overview of Intellectual Property Law – What Are The Driving Forces for Today’s Drug Developers? Chief Judge Elect, The Honorable David Gersten;
Third District Court of Appeals, Miami, FL
       
NIH and the Role of Federal Funding in the Generation of Intellectual Property Mark Rohrbaugh,PhD, Director NIH Office of Technology Transfer; Rockville, MD        
Academic Institutions as Generators, Holders and Transferors of IP Michael Cleare, PhD, Executive Director, Science and Technology Ventures, Columbia University New York, NY   Presentation    
Accelerating Therapeutics Development – A New Vision Blumenstein, President, MRSSI and Senior Advisor to the High Q Foundation, New York, NY   Presentation    

Fundamentals of Clinical Trials in Neurotherapeutics

Title Speaker(s) Duration Presentation Audio Video
Introduction: Stages of Therapeutic Development Roger J. Porter, M.D.        
Nonclinical Studies Eric Siemers, M.D., Eli Lilly & Company        
Trial Design – Early Development Karl Kieburtz, M.D., Professor of Neurology, University of Rochester        
Trial Design – Late Development John Marler, M.D., NIH        
Alternative Trial Designs Michael Krams, M.D., Wyeth        
Clinical Trial Statistics Barbara Tilley, Ph.D., Medical University of South Carolina   Presentation    
Ethics of Clinical Trials Ira Shoulson, M.D., Professor, University of Rochester        
The Clinical Trial Team Lucinda Wilson, Prestwick Pharmaceuticals, Kenneth W. Sommerville M.D., Vice President of Medical Therapeutics, Schwarz Biosciences   Presentation    

Friday, March 9, 2007

Symposium: Ion Channels as Targets for Neurotherapeutics Development

Title Speaker(s) Duration Presentation Audio Video
Profiling Human Ion Channel Gene Variation Jeffrey Noebels, M.D., Ph.D., Baylor College of Medicine        
Sodium and Calcium Channels William Catterall, Ph.D., University of Washington        
KCNQ Potassium Channels: Drug Targets for the Treatment of Epilepsy and Pain Gregory C. Rigdon, Ph.D., Icagen, Inc.   Presentation    
Nicotinic Receptors in Nicotine Addiction and Parkinson's Disease Henry Lester, Ph.D., California Institute of Technology        
Targeting Voltage-gated Calcium Channels in Central and Peripheral Nociceptive Pathways Terrance P. Snutch, PhD, FRSC, University of British Columbia & Neuromed Pharmaceuticals Inc        

Workshop: Disease Specific Clinical Trial Think Tanks

Title Speaker(s) Duration Presentation Audio Video
Stroke Marc Fisher, M.D. (STAIR)        
Epilepsy Jackie French, M.D. (AED IX)   Presentation    
Pain John Farrar, M.D., Ph.D. (IMMPACT)        
Psychiatry Michael F. Green, PhD, (MATRICS)   Presentation    
FDA Collaboration with Neurologic Specialties Through Interactive Clinical Trial Meetings Robert Rappaport, M.D., Center for Drug Evaluation and Research, FDA   Presentation    

Workshop: Neuroethics

Title Speaker(s) Duration Presentation Audio Video
Ethics 2007 - The Honorable David Gersten, Third District Court of Appeals, Miami, FL - A Brief History of Conflict of Interest in Research Roger J. Porter, M.D.        
Justifying the Risks of Research Jason Karlawish, M.D., University of Pennsylvania        
Ethics of Surrogate Consent for Research Jason Karlawish, M.D., University of Pennsylvania        

Dinner Symposium: Neurologic Therapeutics in Pediatrics

Title Speaker(s) Duration Presentation Audio Video
The State of Clinical Pediatric Trials in the United States Edward Kaye, M.D., Vice President of Clinical Research, Genzyme Corporation        
The State of Clinical Pediatric Trials in Europe Virinder Nohria,M.D., Ph.D.   Presentation    
The NIH Contribution to Clinical Trials in the US Anne Zajicek, M.D., Senior Program Officer, NICHD, NIH   Presentation    
The Pediatric Rule--How It Succeeds and How It Fails Russell Katz, M.D., Director of Neuropharmacology, FDA        

Saturday, March 10, 2007

Symposium: Sleep and Neurotherapeutics

Title Speaker(s) Duration Presentation Audio Video
Basic Mechanisms of Sleep Clifford Saper, M.D., Ph.D., Beth Israel Hospital   Presentation    
Epilepsy and Sleep Beth Malow, M.D., M.S., Vanderbilt University   Presentation    
Parkinson's Disease and Sleep David Rye, M.D., Ph.D., Emory University Hospital        
Treatments for Sleep Disorders: Regulatory Challenges and Standards of Evidence Russell Katz, M.D., Director of Neuropharmacology, FDA